baber/WOPTO huggingface dataset:
Patent CA-3082677-A1 (CA)
Title: Fuel additive compositions, and method of use thereof
Inventor: SUBRAMANIYAM MAHESH
IPC: C10L1/185
Filed: 2018-11-05
Abstract: The present invention relates to a fuel additive composition for controlling formation of deposits and for reducing already formed deposits formed in a fuel injection system and engine, or in an internal combustion engine, wherein the fuel additive composition comprises oxide derivative of (a) iso-borneol or (b) borneol, and to a method of use thereof. In one embodiment, the present invention relates to a fuel additive composition for controlling formation of deposits and for reducing already formed deposits formed in a fuel injection system and engine, or in an internal combustion engine, wherein the fuel additive composition comprises (a) iso-borneol or (b) borneol, and to a method of use thereof. In one embodiment, the present invention relates to a fuel additive composition for controlling formation of deposits and for reducing already formed deposits formed in a fuel injection system and engine, or in an internal combustion engine, wherein the fuel additive composition comprises a mixture of oxirane or an oxide compound with (a) iso-borneol or (b) borneol, and to a method of use thereof. In one embodiment, the present invention relates to a composition comprising a fuel and the fuel additive composition of the present invention.
Patent CA-3082962-A1 (CA)
Inventor: DESCHAMPS MARC
IPC: H01M4/38
Filed: 2018-11-19
Abstract: The invention relates to the simultaneous use of a first salt comprising a nitrate anion (NO 3 -) and a second salt comprising an anion other than nitrate, wherein at least one of the first and second salts is a lithium salt, as ionic conductivity promoters in a rechargeable lithium-metal-gel battery. The invention also relates to a lithium-gel battery comprising a mixture of said first salt and said second salt, to a non-aqueous gel electrolyte comprising such a mixture, and to a positive electrode for a lithium battery comprising said mixture.
Patent CA-3083199-A1 (CA)
Inventor: ADAMS RALPH
IPC: C07K16/18
Filed: 2018-12-13
Abstract: The present invention relates to antibodies binding alpha synuclein and fragments thereof capable of binding alpha synuclein as a monomer and in fibrils and preventing alpha synuclein aggregation induced by alpha synuclein fibrils. The antibodies of the present invention are for use in the treatment of alpha synucleinopathies, including Parkinson's disease.
Patent CA-3083205-A1 (CA)
Inventor: REY Gaetan
IPC: B65D50/00
Filed: 2020-06-11
Abstract: L'invention concerne une coiffe de verrouillage pour bloquer un bouchon dans le col d'un récipient. La coiffe comprend un corps externe et une cage (20) configurée pour s'emboiter et se verrouiller axialement dans le corps externe. La cage (20) comporte un anneau supérieur (21), une pluralité n de branches (22) reliées à l'anneau supérieur (21), n/2 ponts médians (25) et n/2 ponts inférieurs (26) disposés en alternance sur le pourtour de la cage (20), chacun reliant deux branches (22) voisines entre elles. Lorsque la coiffe est dans une position de maintien intermédiaire dans laquelle le bouchon est partiellement enfoncé dans le col, les ponts inférieurs (26) entourent au moins en partie une collerette du col ; les ponts médians (25) situés, selon une direction axiale, entre l'anneau supérieur (21) et les ponts inférieurs (26), sont conçu pour ménager un espace ouvert entre eux et la collerette.
Patent CA-3083548-A1 (CA)
Inventor: SOLIMAN TAMER_________________________________________________________S
IPC: H04L12/42
Filed: 2018-12-04
Abstract: A method and system for keeping the control plane of a first ring network and one or more second RSTP networks separate on Layer 2while the data plane of the first and second networks integrated, by using a domain separation logic function in network devices connecting the second networks to the first ring network. The network device tags the BPDUs (bridge protocol data units) received from the second networks with an identifier before releasing to the first ring network, or remove the identifier from the BPDU received from the first ring network before releasing to the corresponding second network if the identifier in the BPDU matches the one associated with that second network. The identifier can be a hidden VLAN ID, a tag within the BPDU frame or a tag added to the control frame all to represent the control domain ID.
Patent CA-3083880-A1 (CA)
Inventor: IKAI KAZUYA
IPC: B23K35/30
Filed: 2018-11-29
Abstract: Provided are: a gas-shielded arc welding wire which enables automatization of welding (continuous automated welding) even with use of a high-Cr welding material by suppressing welding defects such as fusion failure and bead shape defect; and a gas-shielded arc welding method. A gas-shielded arc welding wire which is characterized by containing, in mass% relative to the total mass of the wire, 0.01-0.50% of C, 0.01-1.50% of Si, 0.10-2.50% of Mn, 5-15% of Cr, 0.05-1.50% of Ni, 0.1-2.0% of Mo, 0.1-1.0% of V, 0.01-0.20% of Nb, 0.001-0.050% of REM, 0.0010-0.0200% of S, and 0.025% or less of O (including 0%), and which is also characterized by satisfying formula (1). (1): 3.0 = (Nb + 10 × REM)/(S + O) = 200.0
Patent CA-3088565-A1 (CA)
Title: Method and apparatus for producing particulated whey protein concentrate
Inventor: BADAYEV OLEKSANDAR
IPC: A23C21/00
Filed: 2019-02-07
Abstract: A method for producing particulated whey protein concentrate (WPC) in a continuous-flow high shear reactor (CHSR) is provided. The method includes providing a WPC solution as input, recirculating the WPC solution in the CHSR, and simultaneously heat treating and mechanically heating the WPC solution. The heat to the WPC solution is generated only by the thermal energy created by fluid friction within the recirculated WPC solution.
Patent CA-3091212-A1 (CA)
Inventor: YUNCK THOMAS PATRICK
IPC: G01S7/35
Filed: 2019-03-01
Abstract: A constellation of satellites and associated methods for Earth Observation are disclosed. One method includes transmitting a set of at least four signals towards the Earth using a constellation of at least four satellites and receiving a set of at least four reflected signals from the Earth using the constellation. The method also includes analyzing, using a set of at least four signal analyzers, the set of at least four signals to generate a set of data. Each satellite in the constellation individually houses a signal analyzer in the set of at least four signal analyzers. The method also includes deriving the set of Earth observations using the set of data. Each satellite receives a signal in the set of at least four signals from every other satellite in the constellation.
Patent CA-3093092-A1 (CA)
Inventor: FISHER EYAL
IPC: G16B20/00
Filed: 2019-03-06
Abstract: La présente invention concerne un procédé informatique de détection d'un ADN acellulaire (cfDNA), tel qu'un ADN tumoral circulant, dans un échantillon contenant de l'ADN obtenu d'un patient, le procédé comprenant : (a) la fourniture de loci d'intérêt comprenant au moins 2 loci contenant des mutations représentatifs d'une tumeur du patient ("loci spécifiques du patient") ; (b) la fourniture des données de séquence comprenant des lectures de séquence d'une pluralité de fragments polynucléotidiques d'un échantillon contenant de l'ADN provenant du patient, lesdites lectures de séquence couvrant lesdits au moins 2 loci contenant des mutations de l'étape (a) ; (c) éventuellement, la réalisation de regroupement de lectures pour grouper les lectures de séquence en familles de lectures ; (d) le calcul de la fraction d'allèle mutante à travers tout ou partie desdits au moins 2 loci spécifiques du patient, facultativement, la fraction d'allèle mutante étant calculée par agrégation de lectures mutantes et de lectures totales ; (e) la classification de l'échantillon comme contenant ou non l'ADN acellulaire cible sur la base de la fraction d'allèle mutante calculée. L'invention concerne également des procédés et des systèmes associés.
Patent CA-3096592-A1 (CA)
Title: Facemasks and method for manufacturing the same
Inventor: HARRINGTON DAVID L
IPC: A41D13/11
Filed: 2018-04-13
Abstract: A facemask (100, 322) and automated system for producing facemasks (322) is disclosed. The facemask (100, 322) has a longitudinal direction (102) and a lateral direction (104) that is perpendicular to the longitudinal direction (102). The facemask (100, 322) includes a mask body (106, 316) having a generally rectangular shape, a pair of lateral edges (108, 144, 313) extending in the lateral direction (104), and a pair of longitudinal edges (110, 328) extending in the longitudinal direction (102). At least one tie is attached to the mask body (106, 316) such that the tie extends away from the mask body (106, 316) in a direction (310, 314) that forms an angle (324) with the longitudinal direction (102). The angle (324) ranges from about 10 degrees to about 80 degrees.
Patent CA-3097464-A1 (CA)
Title: Film-forming system with barrier effect, in particular against air pollution, of natural origin and for use in cosmetics
Inventor: MENTINK LEON
IPC: A61K8/73
Filed: 2019-04-17
Abstract: The subject matter of the application is a film-forming system, preferably for cosmetic use, made up of at least one pregelatinised starch and of at least one non-starch polysaccharide selected from: gums of plant origin, preferably gums originating from algae or plants, gums of microbial origin,and cellulose derivatives. The film-forming system according to the invention provides a barrier effect, in particular against air pollution. The application also relates to a method for manufacturing such a film-forming system and to the cosmetic compositions, in particular topical compositions, containing said film-forming system, such as skincare products, hair care products, make-up products, solar protection products, hygiene products or perfumes.
Patent CA-3097591-A1 (CA)
Inventor: SONG COLETTE
IPC: A61K39/00
Filed: 2019-04-12
Abstract: La présente invention concerne des peptides, des protéines, des acides nucléiques et des cellules destinés à être utilisés dans des procédés immunothérapeutiques. En particulier, la présente invention concerne l'immunothérapie du cancer. La présente invention concerne, en outre, des épitopes peptidiques des lymphocytes T associés à une tumeur, seuls ou en combinaison avec d'autres peptides associés à une tumeur, qui peuvent, par exemple, servir de principes actifs pharmaceutiques pour des compositions vaccinales qui stimulent des réponses immunitaires antitumorales, ou pour stimuler des lymphocytes T ex vivo et les transférer aux patients. Des peptides liés à des molécules du complexe majeur d'histocompatibilité (CMH), ou des peptides en tant que tels, peuvent également être des cibles d'anticorps, des récepteurs des lymphocytes T solubles et d'autres molécules de liaison.
Patent CA-3101853-A1 (CA)
Title: Compositions et methodes de traitement de fibrose pulmonaire idiopathique
Inventor: WILLIAMS MARK
IPC: A61P11/00
Filed: 2020-02-14
Abstract: L'invention concerne l'utilisation de composés pharmaceutiquement actifs pour le traitement de maladies pulmonaires chroniques, y compris la fibrose pulmonaire idiopathique. Les composés comprennent des antagonistes du récepteur NMDA, des antagonistes du récepteur du glutamate 2b et des agonistes du récepteur sigma. En particulier, l'utilisation du bromantane, de l'ifenprodil, du radiprodil, du bémithyl et du répirinast sont efficaces dans le traitement de la fibrose pulmonaire idiopathique. L'invention concerne également des méthodes d'utilisation associées.
Patent CA-3106544-A1 (CA)
Title: Anticorps monoclonaux a haute affinite ciblant le glypicane-2 et leurs utilisations
Inventor: HO MITCHELL
IPC: A61K47/68
Filed: 2019-08-06
Abstract: L'invention concerne des anticorps monoclonaux qui se lient au glypicane-2 (GPC2) avec une affinité élevée. L'Invention concerne en outre des immunotoxines et des récepteurs d'antigènes chimériques (CAR) qui comprennent les anticorps décrits ou des fragments de liaison à l'antigène de ceux-ci. Dans certains cas, l'anticorps ou le fragment de liaison à l'antigène est humanisé. Les anticorps et conjugués spécifiques de GPC2 décrits peuvent être utilisés, par exemple, pour le diagnostic ou le traitement de cancers positifs au GPC2, y compris le neuroblastome, le médulloblastome et le rétinoblastome.
Patent CA-3110977-A1 (CA)
Inventor: JHA PRANAB NARAYAN
IPC: G01F1/36
Filed: 2019-07-18
Abstract: Pressure-inducing devices and pressure transducers can be used to detect and quantify liquid pools in hydrocarbon fluid pipelines. Pressure fluctuations can be detected by a pressure transducer, where the pressure fluctuations are the response of a pressure-inducing device outputting a pressure signal in a pipe carrying hydrocarbons. Variation in a pipe diameter caused by pooling or deposition can be estimated using an inverse model. The pooling or depositions can be classified by applying a machine-learning model to the pressure fluctuations. The variation in pipe diameter can be converted to an equivalent liquid volume for pooling locations. A pooling or deposition location and volume can be output and used for determining an action on the pipe to remove the pooling or deposition.
Patent CA-3111355-A1 (CA)
Title: Antimicrobial compositions comprising wollastonite
Inventor: SCHMITZ JORG
IPC: A01N59/06
Filed: 2019-10-04
Abstract: The present invention relates to an antimicrobial composition comprising wollastonite as the antimicrobial agent booster and uses thereof. The present invention also relates to a paint or a coating composition comprising the antimicrobial composition and an article treated with the antimicrobial composition according to the invention.
Patent CA-3111725-A1 (CA)
Inventor: DURHAM TIMOTHY BARRETT
IPC: A61P9/04
Filed: 2019-08-29
Abstract: La présente invention concerne un composé de formule I ou un sel pharmaceutiquement acceptable de celui-ci, et l'utilisation de composés de formule I pour le traitement d'états métaboliques, tels que le diabète sucré de type 2, l'insuffisance cardiaque, la néphropathie diabétique et la stéatohépatite non alcoolique.
Patent CA-3112592-A1 (CA)
Title: Methode et systeme de mesure in vivo et non invasive de niveaux de metabolites
Inventor: O'BRIEN DAVID
IPC: A61B5/145
Filed: 2019-09-13
Abstract: Divers modes de réalisation de l'invention concernent un dispositif compact à résonance magnétique nucléaire (RMN) portable. D'une manière générale, le dispositif compact à RMN portable comprend un boîtier qui fournit un blindage magnétique; un ensemble aimant permanent disposé à l'intérieur du boîtier et possédant un alésage, l'ensemble aimant permanent possédant également une pluralité d'éléments magnétiques assurant ensemble une magnétisation axisymétrique permettant de générer un champ magnétique presque homogène Bo dirigé le long de l'axe longitudinal et l'un des éléments magnétiques possédant une cavité d'échantillon dimensionnée de façon à recevoir un échantillon; un ensemble de compensation comprenant des bobines disposées au niveau de l'axe longitudinal permettant d'assurer une correction de champ magnétique spatial au champ magnétique presque homogène Bo; et un spectromètre comprenant une unité de commande permettant d'appliquer des impulsions de stimulus magnétique à l'échantillon et de mesurer des signaux de retard d'induction libre générés par l'ensemble de protons d'hydrogène à l'intérieur de l'échantillon; ce qui permet de supprimer un signal d'eau à l'aide d'une suppression sélective de fréquence.
Patent CA-3115521-A1 (CA)
Title: Treatment of dermal glands by the application of non-thermal energy
Inventor: JAUREGUI JOHNSTON LAUREN M
IPC: A61B18/14
Filed: 2019-10-09
Abstract: Described herein are methods and apparatuses for reducing or eliminating skin glands (e.g., sebaceous, eccrine and apocrine) with an electric treatment. Also described herein are methods for treating and/or preventing a disorder of a skin gland. For example, described herein are methods of treating sebaceous hyperplasia.
Patent CA-3117055-A1 (CA)
Inventor: HWANG CHAN-SOO
IPC: H04W40/00
Filed: 2019-12-10
Abstract: Presented are methods and systems for a software agent in an AP to recognize a service type used by a wireless communication station and optimize the wireless communication network's operation. Methods comprise acquiring communication status from a communication apparatus that may comprise a wireless communication station, a wireless LAN, wired LAN, and / or a broadband connection; learning a classifier that maps the acquired communication status to service types by analyzing historical communication status; and recognizing the service type of a wireless communication station by inputting a current communication status to the classifier. The recognized service type may be used to diagnose the operation of communication networks and stations coupled to the AP and to optimize the operation of such communication networks and stations.
Patent CA-3118338-A1 (CA)
Title: A vibration resistant fastener assembly
Inventor: BASHETTI AMOL
IPC: F16B39/28
Filed: 2021-05-12
Abstract: Disclosed is a fastener assembly (100) to avoid accidental loosening due to vibrations. The fastener assembly (100) comprises a circular profiled locking washer (105), and a lock nut (110), wherein the locking washer (105) is detachably attachable to an arm (120). The locking washer (105) comprises a plurality of leaf-shaped grooves (125) on a first surface (130), and a central axial aperture (135) for receiving a threaded shaft (150). The lock nut (110) comprises a plurality of spring loaded balls (155) on a surface facing the first surface of the locking washer (105).  During operation, the lock nut (110) is tightened on the threaded shaft (150) by rotating in clockwise direction, and cessation of rotation, latches the plurality of spring loaded balls (155) with the plurality of leaf-shaped grooves (125) to lock the lock nut (110), and hence to withstand counter-rotative torque on the lock nut (110) caused by vibrations.
Patent CA-3120943-A1 (CA)
Title: Seal assembly with anti-rotation and stability features
Inventor: RICHIE AARON PAUL
IPC: F16J15/3244
Filed: 2019-11-22
Abstract: A rotary shaft sealing assembly having a rotatable shaft, a sea! housing having a groove bore located radially outward of and facing the rotatable shaft, and a sealing element in sealing contact with the shaft and groove bore. The sealing element having seal body first and second ends and tangs extending axially from the seal body first end. A shelf member has an outer groove wall and a shelf defining an inner groove wall. The inner and outer groove walls providing axial support to the sealing element in certain conditions of assembly and operation. The seal housing or the shelf member providing restraints, with a portion of the restraints in circumferential alignment with the tangs and blocking rotation of the sealing element. The shelf, located radially between the shaft and the restraints, blocks and prevents loss of the restraints.
Patent CA-3123483-A1 (CA)
Inventor: MCLEOD MICHAEL CHARLES
IPC: A01N43/56
Filed: 2019-12-11
Abstract: L'invention concerne des pyridinyloxybenzènes substitués de formule générale (I) et leur utilisation comme herbicides, en particulier pour lutter contre les plantes adventices et/ou les mauvaises herbes dans des cultures de plantes utiles et/ou comme régulateurs de croissance des plantes pour influencer la croissance des cultures de plantes utiles. La présente invention concerne en outre des agents herbicides et/ou régulateurs de croissance des plantes comprenant un ou plusieurs composés de formule générale (I).
Patent CA-3124295-A1 (CA)
Inventor: FOUGERE RICHARD
IPC: A61B10/00
Filed: 2019-11-20
Abstract: Methods for collecting saliva from the oral cavity of a mammal comprising: placing a mouthpiece of a device comprising the mouthpiece in the oral cavity of a mammal, the mouthpiece comprising a chamber defined by front and rear inner walls and a base inner wall of the mouthpiece, each of the front and rear inner walls of the chamber comprising a plurality of openings, and a switch disposed in the mouthpiece; and the device further comprising a saliva collection reservoir, a fluid supply reservoir, a pump, and means for directing fluid through said device; activating the switch disposed in the mouthpiece to pump saliva from the oral cavity to the saliva collection reservoir for collection; deactivating the pumping of saliva to the saliva collection reservoir; and subsequently pumping fluid from the fluid supply reservoir to the mouthpiece for cleaning or treatment of the oral cavity.
Patent CA-3124769-A1 (CA)
Inventor: PRUSSIA GIOVANNI
IPC: A61K36/00
Filed: 2020-01-24
Abstract: L'invention concerne une composition comprenant de l'acide hyaluronique et un mélange de polynucléotides extraits d'une source naturelle, destinée à être utilisée en tant que substance active dans le traitement thérapeutique et/ou cosmétique pour la régénération de la papille interdentaire ou dans le traitement thérapeutique et/ou cosmétique de la récession de la papille interincisive (syndrome du triangle noir) ou dans le traitement thérapeutique et/ou cosmétique de la parodontite.
Patent CA-3129843-A1 (CA)
Title: Use of plasma membrane particles, liposomes, and exosomes to assay immune cell potency
Inventor: LEE DEAN ANTHONY
IPC: A61K48/00
Filed: 2020-02-14
Abstract: A method of determining the potency of an immune cell is described. The method includes the steps of contacting an immune cell with an effective amount of a cell exosome and detecting the amount of a cytokine produced by the immune cell. Kits for assaying immune cell potency are also described. Potency assays are important for satisfying the FDA requirements for new biological agents, such as immunotherapeutic cells. Methods of using potent immune cells as an immunotherapeutic treatment are described.
Patent CA-3131847-A1 (CA)
Inventor: TULLER TAMIR
IPC: C12N15/67
Filed: 2020-03-26
Abstract: Nucleic acid molecules comprising a mutation that mutation modulates the interaction strength of the nucleic acid molecule to a 16S ribosomal RNA are provided. Methods of improving the translation process of a nucleic acid molecule and producing a nucleic acid molecule optimized for translation, as well as cells comprising the nucleic acid molecules are also provided.
Patent CA-3133184-A1 (CA)
Title: 3-phenyl-5-spirocyclopentyl-3-pyrrolin-2-ones a substitution specifique et leur utilisation en tant qu'herbicides
Inventor: BUSCATO ARSEQUELL ESTELLA
IPC: A01N43/38
Filed: 2020-03-09
Abstract: L'invention concerne des 3-phényl-5-spirocyclopentyl-3-pyrrolin-2-ones à substitution spécifique et leur utilisation en tant qu'herbicides. Cette invention concerne de nouvelles pyrrolin-2-ones à action herbicide, de formule générale (I), ou des sels agrochimiquement acceptables correspondants, ainsi que leur utilisation pour lutter contre des mauvaises herbes ou adventices dans des cultures de plantes utiles.
Patent CA-3134223-A1 (CA)
Inventor: O'DWYER MICHAEL EAMON PETER
IPC: C12N5/0783
Filed: 2020-03-20
Abstract: Immune effector cells and immune effector cell lines are modified to have increased resistance to TRAIL-induced cell death, by knockout of a TRAIL receptor or by linking a TRAIL receptor to an immune effector cell co-stimulatory domain, or both.
Patent CA-3136545-A1 (CA)
Title: Systeme plasmidique
Inventor: HORER MARKUS
IPC: C12N15/86
Filed: 2020-04-14
Abstract: La présente invention concerne des systèmes à deux plasmides, des plasmides auxiliaires et/ou des plasmides vecteurs pour produire des vecteurs AAV recombinants (rAAV). L'invention concerne en outre des procédés utilisant, ou des utilisations des systèmes à deux plasmides, les plasmides auxiliaires et/ou les plasmides vecteurs de l'invention.